GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
RPG Life Sciences Ltd

RPG Life Sciences Board Approves Q2 FY27 Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 29 Oct 2026, 09:45 PM IST  ·  BSE ID: 4ca510f9-934b-4aa3-9d7a-6e4f0fec05f1
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial results for the latest quarter and a new policy for related party deals.
🤖 AI Summary
  • RPG Life Sciences Board approved unaudited standalone and consolidated financial results for Q2 FY27.
  • Results cover the quarter and half-year period ending September 30, 2026.
  • The Board also approved a revised Policy on Related Party Transactions.
  • Trading window for company securities opens 48 hours post-results declaration.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected as the company has formally approved its Q2 FY27 financial results and a revised policy, which will be available on the company website.
🔍
Management Signal
The approval of financial results and a revised policy indicates management's adherence to regulatory compliance and ongoing governance reviews.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Review the detailed Q2 FY27 financial results upon their release for specific performance figures.
Examine the revised Policy on Related Party Transactions on the company website.
Monitor future filings for any significant operational or strategic updates post-results.
LOW RISK This filing is procedural, announcing the approval of results, not the results themselves.
💡 Investor Takeaway
The RPG Life Sciences Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2026, and a revised Related Party Transactions policy.
📅 Company Track Record
RPG Life Sciences' Q1 FY27 standalone profit increased to Rs. 3,057 Lakhs. The Board approved FY26 results in April 2026 and recommended a Rs. 24/- dividend per share (300% of face value).

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was the outcome of the RPG Life Sciences Board meeting on October 29, 2026?
The Board of Directors of RPG Life Sciences approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, and a revised Policy on Related Party Transactions.
Which financial periods do the approved results cover for RPG Life Sciences?
The approved financial results are for the quarter and half-year period concluded on September 30, 2026.
What new policy was approved by the RPG Life Sciences Board?
The RPG Life Sciences Board approved a revised Policy on Related Party Transactions, which will be available on the company's website.
When will the trading window open for RPG Life Sciences shares?
The trading window for dealing in RPG Life Sciences securities will open 48 hours after the declaration of the financial results.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.